<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><identifier>ir-10054-56</identifier><datestamp>2011-12-27T05:54:19Z</datestamp><dc:title>The Morita–Baylis–Hillman adducts of beta-aryl nitroethylenes with other activated alkenes: synthesis and anticancer activity studies</dc:title><dc:creator>DADWAL, MAMTA</dc:creator><dc:creator>MOHAN, RENU</dc:creator><dc:creator>PANDA, DULAL</dc:creator><dc:creator>SHAIKH, MOBIN M</dc:creator><dc:creator>NAMBOOTHIRI, IRISHI NN</dc:creator><dc:subject>synthesis</dc:subject><dc:subject>temperature</dc:subject><dc:subject>nitroalkene</dc:subject><dc:description>The Morita–Baylis–Hillman (MBH) adducts of beta-arylnitroethylenes with methyl vinyl ketone (MVK) and acrylate,formed in moderate to good yield whenmediated by imidazole/LiCl in THF at room temperature, inhibit HeLa cell proliferation by binding to tubulin.</dc:description><dc:publisher>The Royal Society of Chemistry</dc:publisher><dc:date>2007-12-09T17:36:21Z</dc:date><dc:date>2011-11-25T12:14:46Z</dc:date><dc:date>2011-12-26T13:06:28Z</dc:date><dc:date>2011-12-27T05:54:19Z</dc:date><dc:date>2007-12-09T17:36:21Z</dc:date><dc:date>2011-11-25T12:14:46Z</dc:date><dc:date>2011-12-26T13:06:28Z</dc:date><dc:date>2011-12-27T05:54:19Z</dc:date><dc:date>2006</dc:date><dc:type>Article</dc:type><dc:identifier>Chem. Commun. 338–340</dc:identifier><dc:identifier>http://dx.doi.org/ 10.1039/b512267h</dc:identifier><dc:identifier>http://hdl.handle.net/10054/56</dc:identifier><dc:identifier>http://dspace.library.iitb.ac.in/xmlui/handle/10054/56</dc:identifier><dc:language>en</dc:language></oai_dc:dc>